Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics
Titel:
Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics
Auteur:
Lawitz, Eric Sulkowski, Mark Jacobson, Ira Kraft, Walter K. Maliakkal, Benedict Al-Ibrahim, Mohamed Gordon, Stuart C. Kwo, Paul Rockstroh, Juergen Kurt Panorchan, Paul Miller, Michelle Caro, Luzelena Barnard, Richard Hwang, Peggy May Gress, Jacqueline Quirk, Erin Mobashery, Niloufar